カテゴリ： GlobalData, アメリカ, 企業調査

Carmell Therapeutics Corp：企業の製品パイプライン分析2018

◆英語タイトル：Carmell Therapeutics Corp - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C12737
◆発行会社（調査会社）：GlobalData
◆発行日：2018年12月
◆ページ数：34
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio include adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for total joint replacement; enhancer and extender for demineralized bone spine; and tissue healing accelerants to reduce surgical site infections in colorectal surgery, sternotomy, cesarean section, and hysterectomy in preclinical phase. Carmell’s pipeline products are based on its patented plasma-based bioactive materials (PBMs). The company caters its products to surgical site infection and orthopedic markets. Carmell is headquartered in Pittsburgh, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Carmell Therapeutics Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Carmell Therapeutics Corp Company Overview 5
Carmell Therapeutics Corp Company Snapshot 5
Carmell Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Carmell Therapeutics Corp – Pipeline Analysis Overview 8
Carmell Therapeutics Corp – Key Facts 8
Carmell Therapeutics Corp – Major Products and Services 9
Carmell Therapeutics Corp Pipeline Products by Development Stage 10
Carmell Therapeutics Corp Pipeline Products Overview 12
Bone Healing Accelerant – DBM Spine 12
Bone Healing Accelerant – DBM Spine Product Overview 12
Bone Healing Accelerant – Long Bone (Tibia) Fractures 13
Bone Healing Accelerant – Long Bone (Tibia) Fractures Product Overview 13
Bone Healing Accelerant – Shoulder Repair 14
Bone Healing Accelerant – Shoulder Repair Product Overview 14
Bone Healing Accelerant – Total Joint Replacement 15
Bone Healing Accelerant – Total Joint Replacement Product Overview 15
REPAIR Surgical Scaffold 16
REPAIR Surgical Scaffold Product Overview 16
Tissue Healing Accelerant – C-Section/Hysterectomy 17
Tissue Healing Accelerant – C-Section/Hysterectomy Product Overview 17
Tissue Healing Accelerant – Chronic Wound Beds 18
Tissue Healing Accelerant – Chronic Wound Beds Product Overview 18
Tissue Healing Accelerant – Colorectal Surgery 19
Tissue Healing Accelerant – Colorectal Surgery Product Overview 19
Tissue Healing Accelerant – Partial And Full Thickness Grafts 20
Tissue Healing Accelerant – Partial And Full Thickness Grafts Product Overview 20
Tissue Healing Accelerant – Sternotomy 21
Tissue Healing Accelerant – Sternotomy Product Overview 21
Tissue Healing Accelerant – Surgical Wound Healing 22
Tissue Healing Accelerant – Surgical Wound Healing Product Overview 22
Carmell Therapeutics Corp – Key Competitors 23
Carmell Therapeutics Corp – Key Employees 24
Carmell Therapeutics Corp – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Carmell Therapeutics Corp, Recent Developments 26
Jun 22, 2017: Carmell Therapeutics announced the issuance of Canadian Patent No. 2701187 for METHODS AND APPARATUS FOR MANUFACTURING PLASMA BASED PLASTICS 26
Jun 22, 2017: Carmell Therapeutics announced the issuance of Canadian Patent No. 2701187 for Methods and Apparatus for Manufacturing Plasma Based Plastics 26
May 09, 2017: Carmell Therapeutics expands manufacturing capabilities to support Phase III clinical trials 27
Oct 05, 2016: Carmell Therapeutics New Management Team 27
Jun 24, 2016: Carmell announces the awarding of a new U.S. Patent that covers the use of the Company’s plasma-based materials as drug delivery vehicles 28
Apr 07, 2016: Dr. James Hart joins Carmell Therapeutics as new Chief Medical Officer 28
Feb 16, 2016: Carmell Therapeutics Announces Appointment of Randy Hubbell to President and Chief Executive Officer 28
May 15, 2015: Carmell Therapeutics’ Plasma-Based Materials Shown to be Effective Antibiotic Delivery Vehicles 29
Dec 23, 2014: Carmell Therapeutics Ends 2014 with Addition of a New Patent to its Growing Portfolio 29
Nov 14, 2014: Pittsburgh researchers’ bone putty could revolutionize how broken bones mend 30
Appendix 31
Methodology 31
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Carmell Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Carmell Therapeutics Corp Pipeline Products by Equipment Type 6
Carmell Therapeutics Corp Pipeline Products by Indication 7
Carmell Therapeutics Corp, Key Facts 8
Carmell Therapeutics Corp, Major Products and Services 9
Carmell Therapeutics Corp Number of Pipeline Products by Development Stage 10
Carmell Therapeutics Corp Pipeline Products Summary by Development Stage 11
Bone Healing Accelerant - DBM Spine - Product Status 12
Bone Healing Accelerant - DBM Spine - Product Description 12
Bone Healing Accelerant - Long Bone (Tibia) Fractures - Product Status 13
Bone Healing Accelerant - Long Bone (Tibia) Fractures - Product Description 13
Bone Healing Accelerant - Shoulder Repair - Product Status 14
Bone Healing Accelerant - Shoulder Repair - Product Description 14
Bone Healing Accelerant - Total Joint Replacement - Product Status 15
Bone Healing Accelerant - Total Joint Replacement - Product Description 15
REPAIR Surgical Scaffold - Product Status 16
REPAIR Surgical Scaffold - Product Description 16
Tissue Healing Accelerant - C-Section/Hysterectomy - Product Status 17
Tissue Healing Accelerant - C-Section/Hysterectomy - Product Description 17
Tissue Healing Accelerant - Chronic Wound Beds - Product Status 18
Tissue Healing Accelerant - Chronic Wound Beds - Product Description 18
Tissue Healing Accelerant - Colorectal Surgery - Product Status 19
Tissue Healing Accelerant - Colorectal Surgery - Product Description 19
Tissue Healing Accelerant - Partial And Full Thickness Grafts - Product Status 20
Tissue Healing Accelerant - Partial And Full Thickness Grafts - Product Description 20
Tissue Healing Accelerant - Sternotomy - Product Status 21
Tissue Healing Accelerant - Sternotomy - Product Description 21
Tissue Healing Accelerant - Surgical Wound Healing - Product Status 22
Tissue Healing Accelerant - Surgical Wound Healing - Product Description 22
Carmell Therapeutics Corp, Key Employees 24
Glossary 33

List of Figures
Carmell Therapeutics Corp Pipeline Products by Equipment Type 6
Carmell Therapeutics Corp Pipeline Products by Development Stage 10

★海外企業調査レポート[Carmell Therapeutics Corp：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Mondelez International Inc (MDLZ)：企業の財務・戦略的SWOT分析
    Mondelez International Inc (MDLZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Paranta Biosciences Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Paranta Biosciences Ltd (Paranta Biosciences) is a biopharmaceutical company that develops bio-therapeutics for the treatment of inflammatory and fibrotic diseases. The company develops product candidate PB01, a recombinant human follistatin-288 used for the treatment of cystic fibrosis lung …
  • Crowley Maritime Corporation：石油・ガス：M&Aディール及び事業提携情報
    Summary Crowley Maritime Corp (Crowley Maritime) is a transportation and logistics company that offers marine solutions and services. Its service portfolio includes shipping and logistics, Alaska fuel sales and distribution, petroleum and chemical transportation, harbor ship assist and tanker escort …
  • WAVE Life Sciences Ltd (WVE)：企業の財務・戦略的SWOT分析
    Summary Wave Life Sciences Ltd (Wave Life Sciences) formerly WAVE Life Sciences Pte Ltd, discovers, develops and commercializes medicines for genetic diseases. The company's pipeline comprises an mRNA transcript candidates: WVE-120101 and WVE-120102 for Huntington's disease; ATXN3 gene candidate for …
  • Kesoram Industries Ltd：企業の戦略・SWOT・財務情報
    Kesoram Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Kesoram Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CapitalSource：企業の戦略・SWOT・財務情報
    CapitalSource - Strategy, SWOT and Corporate Finance Report Summary CapitalSource - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • C3J Therapeutics Inc-製薬・医療分野：企業M&A・提携分析
    Summary C3J Therapeutics Inc (C3J), formerly C3 Jian Inc, is a clinical-stage biotechnology company which concentrates on the development and commercialization of targeted and pathogen specific, antimicrobials that treat and prevent diseases caused by microbial dysbiosis. Its pipeline product portfo …
  • Edison SpA：企業の発電所・SWOT分析2018
    Edison SpA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Dr. Ci:Labo Co., Ltd.：企業の戦略・SWOT・財務情報
    Dr. Ci:Labo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dr. Ci:Labo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • National Grid Plc (NG)：石油・ガス：M&Aディール及び事業提携情報
    Summary National Grid Plc (National Grid) is an energy utility. It transmits and distributes electricity and gas. The company owns and operates electricity and gas transmission and distribution networks; and is also the system operator for the Scottish networks. National Grid provides installation a …
  • Duke Energy Carolinas LLC-エネルギー分野：企業M&A・提携分析
    Summary Duke Energy Carolinas, LLC (Duke Energy Carolinas), a subsidiary of Duke Energy Corporation, is a regulated electric utility, which generates, transmits, distributes and sells energy. The company produces power from nuclear, coal, oil and gas, hydro, and solar sources. It is subject to the r …
  • DSE, Inc.：企業の戦略・SWOT・財務情報
    DSE, Inc. - Strategy, SWOT and Corporate Finance Report Summary DSE, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • HeartWare International Inc：企業の戦略的SWOT分析
    HeartWare International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Macy’s Inc：企業の戦略・SWOT・財務情報
    Macy's Inc - Strategy, SWOT and Corporate Finance Report Summary Macy's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Xeikon N.V.：企業の戦略的SWOT分析
    Xeikon N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Orient Pharma Co Ltd (4166)：製薬・医療：M&Aディール及び事業提携情報
    Summary Orient Pharma Co Ltd (Oripharm) is a pharmaceutical company that manufactures and distributes therapeutic drugs. The company develops drugs for anti-psychotics, Alzheimer’s disease, psychostimulants and Parkinson’s disease. Its drug delivery technologies include multi stages controlled techn …
  • Esprit Holdings Limited
    Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • CCL Industries Inc.：企業のM&A・事業提携・投資動向
    CCL Industries Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CCL Industries Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Amcor Limited
    Amcor Limited - Strategy, SWOT and Corporate Finance Report Summary Amcor Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Nutreco NV：企業のM&A・事業提携・投資動向
    Nutreco NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nutreco NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆